Characterization of ph- and thermosensitive hydrogel as a vehicle for controlled protein delivery.
N-[(2-Hydroxy-3-trimethylammonium)propyl] chitosan chloride (HTCC) was chemically modified using glycidyltrimethylammonium chloride (GTMAC). A new composite hydrogel was prepared using the mixture of HTCC and α-β-glycerophosphate (α-β-GP). The gelation of HTCC/GP mainly depended on the concentration and proportion of HTCC and GP. Thermogravimetric analysis exhibited high stability of HTCC/GP hydrogels. Surface morphology assay demonstrated that HTCC/GP hydrogels were well constructed with three-dimensional (3D) porous structures in the range of 5 of 40 μm. The insulin was entrapped during the formation of hydrogel. In vitro, the insulin release was controlled by modifying the composition, drug loading, and pH condition. The hydrogel dissolved and released drug quickly under acidic condition, whereas it absorbed water and released drug slowly under neutral or basic conditions. The hydrogels were biocompatible, and the cells could adhere to and then migrated to the hydrogels. Furthermore, these cells were viable and retained 3D morphology inside the hydrogels. Interestingly, HTCC/GP hydrogel showed both thermo- and pH-sensitive properties. There are potential applications in tissue engineering, cell encapsulation, and intelligent drug delivery systems.
Shi
Wenping
W
Tianjin Institute of Sexually Transmitted Diseases, General Hospital, Tianjin Medical University, Tianjin 300052, China.
Ji
Yanwen
Y
Zhang
Xinge
X
Shu
Shujun
S
Wu
Zhongming
Z
D000818:Animals; D002470:Cell Survival; D048271:Chitosan / Q000031:analogs & derivatives* / Q000737:chemistry; D003692:Delayed-Action Preparations; D004337:Drug Carriers; D016503:Drug Delivery Systems; D004355:Drug Stability; D004852:Epoxy Compounds / Q000737:chemistry*; D005079:Excipients; D005994:Glycerophosphates / Q000737:chemistry*; D020100:Hydrogels / Q000737:chemistry*; D006863:Hydrogen-Ion Concentration; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics; D007328:Insulin / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics; D051379:Mice; D008968:Molecular Conformation; D041681:NIH 3T3 Cells; D000644:Quaternary Ammonium Compounds / Q000737:chemistry*; D012212:Rheology; D013696:Temperature
D003692:Delayed-Action Preparations; D004337:Drug Carriers; D004852:Epoxy Compounds; D005079:Excipients; D005994:Glycerophosphates; D020100:Hydrogels; D007004:Hypoglycemic Agents; D007328:Insulin; C550160:N-(2-hydroxypropyl)-3-trimethylammonium chitosan; D000644:Quaternary Ammonium Compounds; C045006:glycidyl trimethylammonium; D048271:Chitosan